Biotech IPO watch
Upcoming & recent drug-developer IPOs — filed, expected, and just-priced. Source: Nasdaq IPO calendar · not financial advice
Expected soon
price range set, pricing within days0none right now
Filed (S-1 in)
registered with the SEC, awaiting a date16| Company | Ticker | Exchange | Sector | Price | Deal size | Date |
|---|---|---|---|---|---|---|
| Avalyn Pharma Inc. | AVLN | — | Respiratory | — | $300M | 2026-04-08 |
| Hemab Therapeutics Holdings, Inc. | COAG | — | Biotech | — | $302M | 2026-04-10 |
| Seaport Therapeutics, Inc. | SPTX | — | biotech | — | $255M | 2026-04-10 |
| ROKIT America, Inc. | RKAM | — | Biotech | — | $32M | 2026-04-15 |
| Odyssey Therapeutics, Inc. | ODTX | — | Therapeutics | — | $279M | 2026-04-17 |
| Tarsier Pharma Ltd. | TARX | — | pharma | — | $64M | 2026-04-21 |
| Eloxx Pharmaceuticals, Inc. | ELOX | — | Pharmaceuticals | — | $33M | 2026-05-07 |
| Parabilis Medicines, Inc. | PBLS | — | Pharmaceuticals | — | $670M | 2026-05-19 |
| Scribe Therapeutics, Inc. | SCTX | — | biotech | — | $123M | 2026-07-02 |
| Apnimed, Inc. | APMD | — | Respiratory | — | $100M | 2026-07-10 |
| Attovia Therapeutics, Inc. | ATTO | — | Immunology | — | $100M | 2026-07-14 |
| Vogenx, Inc. | VOGX | — | Biotechnology | — | $75M | 2026-07-15 |
| Braveheart Bio, Inc. | BRVE | — | Cardiovascular | — | $100M | 2026-07-15 |
| NuvOx Therapeutics, Inc. | NUOX | — | Therapeutics | — | $26M | 2026-07-17 |
| BlossomHill Therapeutics, Inc. | BLSM | — | Oncology | — | $100M | 2026-07-17 |
| Latigo Biotherapeutics, Inc. | LTGO | — | Biotherapeutics | — | $100M | 2026-07-17 |
Recently priced
just began trading3| Company | Ticker | Exchange | Sector | Price | Deal size | Date |
|---|---|---|---|---|---|---|
| Kailera Therapeutics, Inc. | KLRA | Nasdaq Global Select | Therapeutics | $16.00 | $625M | 2026-04-17 |
| Lakewood-Amedex Biotherapeutics Inc. | LABT | Nasdaq Capital | Biotherapeutics | — | — | 2026-04-23 |
| Optimi Health Corp. | OPTH | Nasdaq Capital | Therapeutics | $6.25 | $15M | 2026-05-20 |